We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| IND-SWIFT LABORATORIES LTD. | 1705.04 | 79.9 | 1526.44 | 0.96 | 734.0 | 33.3 |
| Shree Ganesh Remedies Limited | 310.05 | 49.56 | 303.15 | 3.86 | 668 | 30.6 |
| Prevest Denpro Limited | NA | NA | NA | NA | 660 | 34.9 |
Ind-Swift Laboratories Ltd., with Security Code 532305, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 299.0 | 270.3 | 276.3 | 381.7 | 30.5 | 2.7 | 1.4 | 148.0 |
| Expenses | 239.2 | 206.9 | 222.5 | 286.3 | 35.0 | 14.7 | 10.2 | 144.9 |
| Operating Profit | 59.8 | 63.4 | 53.8 | 95.5 | -4.5 | -12.0 | -8.8 | 3.1 |
| OPM % | 20% | 23.46% | 19.48% | 25.01% | -14.88% | -443.39% | -625.99% | 2.08% |
| Other Income | 5.6 | 7.4 | 7.1 | 411.8 | 11.1 | 12.9 | 13.8 | 14.6 |
| Interest | 20.4 | 21.1 | 21.1 | 11.5 | 0.2 | 0.4 | 0.1 | 1.2 |
| Depreciation | 13.9 | 13.2 | 13.6 | 12.7 | 0.3 | 0.2 | 0.2 | 6.7 |
| Profit before tax | 31.1 | 36.5 | 26.3 | 96.6 | 6.2 | 0.3 | 4.6 | 9.8 |
| Tax % | -17.5% | -17.5% | -17.7% | -27.6% | 0% | 0% | 0% | 17.4% |
| Net Profit | 17.1 | 30.1 | 21.7 | 349.6 | 6.2 | 0.3 | 4.6 | 8.1 |
| EPS in Rs | 2.89 | 5.09 | 3.66 | 59.17 | 1.05 | 0.05 | 0.78 | 1.08 |
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 287.5 | 393.3 | 33.2 | 12.0 | 8.7 | 138.2 | 152.7 | 152.6 |
| Expenses | 236.4 | 407.7 | 43.0 | 23.8 | 23.2 | 93.9 | 149.1 | 151.2 |
| Operating Profit | 51.2 | -14.4 | -9.8 | -11.8 | -14.5 | 44.3 | 3.6 | 1.4 |
| OPM % | 17.79% | -3.65% | -29.59% | -98.63% | -167.72% | 32.07% | 2.36% | 0.93% |
| Other Income | 7.1 | 411.8 | 11.1 | 13.0 | 13.8 | 220.3 | 14.6 | 17.9 |
| Interest | 21.1 | 11.5 | 0.2 | 0.4 | 0.1 | 26.8 | 1.2 | 2.0 |
| Depreciation | 13.6 | 12.7 | 0.3 | 0.2 | 0.2 | 7.4 | 6.7 | 7.0 |
| Profit before tax | 23.7 | -13.3 | 0.9 | 0.6 | -1.1 | 14.6 | 10.4 | 10.3 |
| Tax % | -17.9% | -36% | -3% | -31.7% | 99.5% | -3.5% | 16.5% | 22.2% |
| Net Profit | 19.4 | 238.9 | 0.9 | 0.4 | 0.0 | 222.3 | 8.8 | 8.0 |
| EPS in Rs | 3.29 | 40.42 | 0.16 | 0.07 | 0 | 0 | 1.17 | 0.96 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -63% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 48% |
| 3 Years: | 222% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 25% |
| 3 Years: | 6% |
| 1 Year: | -32% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 42% |
| 3 Years: | 260% |
| TTM: | 188% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 25% |
| 3 Years: | 6% |
| 1 Year: | -32% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|